Our team is committed to enhancing our understanding of human disease.
Transforming the measurement of disease progression in vivo using noninvasive biosensors.
Bioengineered, tunable sensors that are designed for each protease-mediated disease.
Evolving the way diseases are understood, tracked and treated to accelerate the development of drugs.
Transforming the way diseases are detected, tracked, treated, and understood.
Leveraging the profound advances in engineering, medicine, biotechnology, and machine learning.
We are proud to be members of the pre-eminent Cambridge biotech community.
We are at the forefront of a changing paradigm in healthcare; we hope to improve the way we understand and treat diseases. If you are as ambitious as we are learn about our values and culture.